Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and other hematological parameters in psoriasis patients

[1] Ritchlin CT(2016)New therapies for psoriasis and psoriatic arthritis Curr Opin Rheumatol 28 204-210

[2] Krueger JG(2014)Diagnosis and classification of psoriasis Autoimmun Rev 13 490-495

[3] Raychaudhuri SK(2018)Associations between the neutrophil-to-lymphocyte and the platelet-to-lymphocyte ratios and the presence and severity of psoriasis: a systematic review and meta-analysis Clin Exp Med 19 37-45

[4] Maverakis E(2008)Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach Br J Dermatol 159 10-17

[5] Raychaudhuri SP(2012)The concept of psoriasis as a systemic inflammation: implications for disease management J Eur Acad Dermatol Venereol 26 3-11

[6] Paliogiannis P(2017)What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes 10 12-1121

[7] Satta R(2017)Neutrophil–lymphocyte ratio, platelet–lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: response to therapy with biologics J Dermatol 44 1112-S131

[8] Deligia G(2019)Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis Eur J Clin Investig 49 e13037-1104

[9] Farina G(2017)Neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitus Diabetes Metab Syndr 11 S127-100

[10] Bassu S(2014)Neutrophil-to-lymphocyte ratio may predict subclinical atherosclerosis in patients with psoriasis Echocardiography 31 1095-310

[1] Ritchlin CT(2016)New therapies for psoriasis and psoriatic arthritis Curr Opin Rheumatol 28 204-210

[2] Krueger JG(2014)Diagnosis and classification of psoriasis Autoimmun Rev 13 490-495

[3] Raychaudhuri SK(2018)Associations between the neutrophil-to-lymphocyte and the platelet-to-lymphocyte ratios and the presence and severity of psoriasis: a systematic review and meta-analysis Clin Exp Med 19 37-45

[4] Maverakis E(2008)Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach Br J Dermatol 159 10-17

[5] Raychaudhuri SP(2012)The concept of psoriasis as a systemic inflammation: implications for disease management J Eur Acad Dermatol Venereol 26 3-11

[6] Paliogiannis P(2017)What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes 10 12-1121

[7] Satta R(2017)Neutrophil–lymphocyte ratio, platelet–lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: response to therapy with biologics J Dermatol 44 1112-S131

[8] Deligia G(2019)Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis Eur J Clin Investig 49 e13037-1104

[9] Farina G(2017)Neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitus Diabetes Metab Syndr 11 S127-100

[10] Bassu S(2014)Neutrophil-to-lymphocyte ratio may predict subclinical atherosclerosis in patients with psoriasis Echocardiography 31 1095-310